Azilsartan 40mg Tablet Franchise in Ahmedabad

Antihypertensive Tablet Supplier in Bangalore

Azilsartan Blood Pressure Tablet Distributor in Hyderabad

Hypertension Treatment Tablet Franchise Opportunity in Jaipur

Cardiac Care Tablet Stockist in Mumbai
Azilsartan Tablet Export & Manufacturing in Chandigarh

Home/Products /azilsartan-40-mg-tablet

Aziltry 40 Tablet

Composition : Azilsartan (40mg) tablet

Dosage Form : Tablet

Packaging Type : Alu Alu

Packaging : 10*10

Price : ₹1/-

Aziltry 40 Tablet contains Azilsartan 40mg, a potent angiotensin II receptor blocker (ARB) used in the effective management of hypertension. By blocking the action of angiotensin II, it helps relax blood vessels, improve blood flow, and achieve consistent blood pressure control.

Azilsartan is known for its strong and sustained antihypertensive effect, making it suitable for once-daily dosing in patients with essential hypertension. Regular use supports long-term cardiovascular protection and helps reduce the risk of complications such as stroke, heart attack, and kidney damage.

For hospitals, clinics, and pharmaceutical distributors, Aziltry 40 Tablet is a high-rotation chronic therapy product, widely prescribed in cardiology, internal medicine, and general practice settings. Continuous patient use ensures steady demand and repeat procurement across healthcare channels.

Adding Aziltry 40 Tablet to your portfolio strengthens your cardiovascular and chronic-care segment, creating strong opportunities in retail pharmacy supply, institutional procurement, long-term therapy programs, export markets, and third-party manufacturing. Its clinical reliability and chronic-use nature make it a commercially stable and valuable product.

Read More

About the Product

Aziltry 40 Tablet contains Azilsartan 40mg, a potent angiotensin II receptor blocker (ARB) used in the effective management of hypertension. By blocking the action of angiotensin II, it helps relax blood vessels, improve blood flow, and achieve consistent blood pressure control.

Azilsartan is known for its strong and sustained antihypertensive effect, making it suitable for once-daily dosing in patients with essential hypertension. Regular use supports long-term cardiovascular protection and helps reduce the risk of complications such as stroke, heart attack, and kidney damage.

For hospitals, clinics, and pharmaceutical distributors, Aziltry 40 Tablet is a high-rotation chronic therapy product, widely prescribed in cardiology, internal medicine, and general practice settings. Continuous patient use ensures steady demand and repeat procurement across healthcare channels.

Adding Aziltry 40 Tablet to your portfolio strengthens your cardiovascular and chronic-care segment, creating strong opportunities in retail pharmacy supply, institutional procurement, long-term therapy programs, export markets, and third-party manufacturing. Its clinical reliability and chronic-use nature make it a commercially stable and valuable product.

Some patients may experience dizziness, headache, fatigue, or low blood pressure. Rarely, kidney function changes, hyperkalemia, or allergic reactions may occur.

Aziltry 40 Tablet is indicated for the treatment of hypertension (high blood pressure). It helps reduce the risk of cardiovascular events such as stroke and heart attack when used as part of a comprehensive blood pressure management plan.

Use under medical supervision. Avoid use during pregnancy. Monitor blood pressure, kidney function, and potassium levels regularly. Do not discontinue abruptly without consulting a doctor.

Store in a cool, dry place below 25°C, away from light and moisture. Keep out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation